Reports

Ideas That Generate Results

Global miRNA Market Outlook to 2020

Global miRNA Market Outlook to 2020

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Oct, 2015| No. of Pages : 130

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1500.00
CD-ROM Mail Delivery
US$ 1700.00
Hard Copy Mail Delivery
US$ 1700.00
Electronic Access - Multi-User License
US$ 2200.00
1. Analyst View

2. Research Methodology

3. miRNA - An Introduction

4. miRNA Techniques
    4.1 miRNA Purification
    4.2 miRNA Labeling
    4.3 miRNA Linear Amplification
    4.4 miRNA Microarrays
    4.5 miRNA qRT-PCR
    4.6 miRNA Inhibition
    4.7 miRNA Transfection

5. Industry Overview
    5.1 Market Drivers
           5.1.1 Growing Focus on Developing of miRNA-based Diagnostic Biomarkers
           5.1.2 Technological Advancements
           5.1.3 Rise in miRNA-based Researches
           5.1.4 Increasing Prevalence of Chronic Diseases
           5.1.5 Rising Investments in miRNA Market
    5.2 Market Opportunities
           5.2.1 Increasing miRNA-based Research in Cardiovascular Biology and Disease
           5.2.2 Therapeutics Application Offers Significant Growth Opportunity
    5.3 Market Challenges
           5.3.1 High Cost of developing miRNA-based Tools
           5.3.2 Technological Challenges in Developing miRNA-based Therapeutics
    5.4 Market Trends
           5.4.1 Increasing Strategic Alliances in the Market
           5.4.2 Next Generation Sequencing: Gaining Momentum

6. Global miRNA Market Outlook to 2020
     6.1 miRNA Tools and Services Market

7. Global miRNA Market by Applications
    7.1 Research
    7.2 Diagnostics
    7.3 Drug Development

8. Global miRNA Market by End User
    8.1 Research Labs and Institutes
    8.2 Biotechnology Industry
    8.3 Hospitals and Diagnostic Centers

9. Global miRNA Market by Geography
    9.1 The Americas
    9.2 Europe
    9.3 Asia Pacific (APAC)

10. Global miRNA Market, by Disease
       10.1 Introduction
       10.2 Cancer
       10.3 Neurological Diseases
       10.4 Cardiovascular Diseases
       10.5 Hepatic Diseases
       10.6 Other Diseases

11. Portfolio of miRNA Pathway Drugs Candidates

12. Key Players
      12.1 QIAGEN
      12.2 Sigma-Aldrich Corporation (A Subsidiary of Merck KGaA)
      12.3 Thermo Fisher Scientific, Inc.
      12.4 Agilent Technologies Inc.
      12.5 Affymetrix
      12.6 Integrated DNA Technologies
      12.7 Exiqon
      12.8 Mirus Bio LLC
      12.9 Wako Pure Chemical Industries
      12.10 Rosetta Genomics Ltd.
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.